Skip to content

Clinical investigation into colonic dialysis with rhubarb that improves gut microbiota and enterogenous endotoxins for patients with stage 4, 5 (non-dialysis) Chronic kidney disease

Clinical investigation into colonic dialysis with rhubarb that improves gut microbiota and enterogenous endotoxins for patients with stage 4.5 (non-dialysis) chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-14004823
Enrollment
Unknown
Registered
2014-06-19
Start date
2014-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

colonic dialysis with rhubarb group:colonic drug delivery with rhubarb

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Matching the diagnostic criteria for stage 4, 5 (non-dialysis) of chronic kidney disease (referring to KDIGO guidelines, 2012, GFR < 29.9 ml/min) at the age between 20 and 80 year-old; 2. Stable baseline values for the index of blood pressure, blood glucose, electrolyte, and anemia etc., which are controlled as within targeted ranges in treating chronic kidney disease as possibleand strictly abiding by the living management and dietary requirements for chronic kidney diseases (high quality protein diet); 3. No use of related antibiotics, hormones and immunosuppressants in the last three months; 4. The absence of the rectum related disorders (hemorrhoids, rectocele, anal fistula, etc.) at present;5.Patients willingness to participate in scientific research projects and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. No major complications related to cardiovascular and respiratory system diseases; 2. Unable to cooperate with enema treatments; 3. Failure to tolerate enema treatments due to nervousness and too young or too old ages; 4. No gastrointestinal diseases in the last year (including chronic gastroenteritis, irritable bowel syndrome and others related to the intestinal diseases) .

Design outcomes

Primary

MeasureTime frame
Gut microbiota;Indoxyl sulfate;P-cresyl sulfate;

Countries

China

Contacts

Public ContactChuan Zou

Guangdong Provincial Hospital of Chinese Medicine

doctorzc541888@126.com+86 13570510358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026